Ultimately, on January 1st, 2024, the North Carolina State Health Plan made the decision to exclude GLP-1s for weight loss from coverage, while grandfathering in current utilizers
Efficacy analyses were performed on two sets: the full analysis set, defined as all unique randomized patients grouped according to the treatment assigned at randomization, thereby following the intent-to-treat principle, and an on-treatment analysis, defined as all exposed patients while they were receiving treatment (that is, had received at least one dose in the previous 35 d), grouped according to the treatment that they received
Baseline IGF-1 levels typically return to pre-protocol range within 34 weeks of cessation without intervention
However, if you have specific sensitivities or concerns, its recommended to perform a patch test or consult with a dermatologist before use